Equiva has unveiled a new digital signage solution giving healthcare organizations (HCOs) a flexible framework to deliver educational, informational and promotional content to patients, visitors, and staff across waiting rooms, high-traffic public areas and employee-only locations.
“Digital signage is often overlooked or is an afterthought in healthcare organizations, yet it provides numerous opportunities to engage captive waiting room audiences and share content to promote offerings,” stated Equiva CEO Nir Altman. “Our solution empowers HCOs to leverage digital signage quickly, flexibly, affordably and securely.”
According to Altman, Equiva’s seen an uptick in use of digital signage to support employee retention and wellness programs, often dovetailing with EAP offerings, self-care reminders, and employee gratitude campaigns. “This is increasingly important to amidst today’s high burn-out rates,” he stated.
Equiva’s cloud-based digital signage solution is optimized for healthcare security demands and can be deployed in less than four weeks, with flexibility to create content and manage updates to meet the needs of individual departments and units while also supporting company-wide strategic initiatives. The solution enhances the company’s health relationship management platform, an integrated omnichannel solution for collaborative, hyper-targeted digital health engagement.
Healthmine presented an in-depth webinar on the laundry list of proposed measure changes in the 2023 MA and Part D Advance Notice and shared how teams can begin evolving their strategies to prepare for the future.
Prenosis, a precision medicine company, has announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over $20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others.
The company enlists machine learning algorithms for deep biological data and broad clinical data to create comprehensive maps of acute disease. It uses the maps to develop and market navigational tools to improve patient care by illuminating the optimal treatment pathways for each patient.
To read more, click here.
9am.health, a new virtual diabetes clinic, is proud to announce its collaboration with BioReference Laboratories, Inc., an OPKO Health company, to offer their patients the ability to get blood drawn for diagnostic laboratory tests from the convenience of their own home or workplace, leveraging Scarlet Health®,
BioReference’s integrated digital platform.
“Labs are a key part of managing chronic diseases and adjusting medication doses. Unfortunately, the frequency and burden associated with going to a lab can lead to patients dropping off from their regular therapy schedule,” says Paul Geevarghese, Chief Medical Officer at 9am.health. ”By sending a health professional to the home, we can collect the most comprehensive data on blood glucose, kidney function, liver function, cholesterol, electrolytes, and more while removing the unnecessary barriers that make it hard to keep up with traditional medical care.”
Picture: akindo, Getty Images
